Open AccessExpression of programmed death ligand-1 and programmed death 1 in hepatocellular carcinoma and its clinical significance
Author(s) -
Junjiajia Long,
Tao Qu,
X.F. Pan,
Xuan Tang,
H H Wan,
Pengfei Qiu,
Yanhua Xu
Publication year - 2017
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.204850
Subject(s) - hepatocellular carcinoma , immunohistochemistry , medicine , stromal cell , pd l1 , stage (stratigraphy) , pathology , cancer research , clinical significance , pathogenesis , biomarker , oncology , cancer , biology , immunotherapy , paleontology , biochemistry
To investigate the correlation between the expression of programmed death 1 (PD-1) and PD ligand-1 (PD-L1) in hepatocellular carcinoma (HCC) and clinical parameters.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom